NCT05861375已完成不适用
Assessment of Liver Damage Using the Fibroscan in Patients With Anorexia Nervosa
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- Liver fibrosis prevalence in patients with Anorexia nervosa
研究概览
简要总结
The main goal of the Liver Biomarkers in Anorexia Nervosa (LIBAN) study is to determine the prevalence of liver fibrosis in patient with Anorexia Nervosa.
详细描述
Prevalence of hepatic fibrosis will be non-invasively investigated, in the Anorexia Nervosa inpatient population, using the Fibroscan ®. Furthermore, liver blood markers will be assessed.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient over 15 years old
- •Diagnosis of Restricted Eating Disorders including Anorexia Nervosa according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- •Admission to the endocrinology, diabetology and nutrition department of the Nantes University Hospital.
排除标准
- •Chronic active viral hepatitis
- •Hemochromatosis
- •Other genetic, autoimmune, toxic or drug-induced hepatitis
- •Treatment with a drug known to induce fatty liver disease (amiodarone, carbamazepine, tamoxifen, valproate, clozapine, anti-retrovirals) unless the dose has been stable for ≥ 3 months
- •Excessive alcohol consumption (≥ 30 grams per day in men, ≥ 20 grams per day in women)
研究组 & 干预措施
Non applicable (NA)
Patients with Anorexia Nervosa hospitalized for malnutrition
干预措施: Fibroscan (Diagnostic Test)
结局指标
主要结局
Liver fibrosis prevalence in patients with Anorexia nervosa
时间窗: Day one
Liver stiffness will be assessed using Fibroscan (kPA) within the 24 hours following admission to the endocrinology, diabetology and nutrition department.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker AnalysisAnorexia NervosaNCT06262165Nantes University Hospital19
已完成
不适用
Prospective Evaluation of FibroScan in Patients Treated With MethotrexateLiver FibrosisNCT00673101Association HGE CHU Bordeaux Sud1,871
已完成
不适用
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective StudyDiabetesNCT01306110Association HGE CHU Bordeaux Sud277
招募中
不适用
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis DatabaseDisease of Liver and Bile DuctNCT02897908State University of New York at Buffalo1,000
已完成
不适用
Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis BChronic Hepatitis BHepatic SteatosisNCT06573190Yaşar Bayındır, MD70